Article
Genetic diversity of the human adenovirus species C DNA polymerase.
Antiviral research - 1 Aug 2018
Feghoul Linda, Mercier-Delarue Séverine, Salmona Maud, Ntsiba Nora, Dalle Jean-Hugues, Baruchel André, Klonjkowski Bernard, Richardson Jennifer, Simon François, LeGoff Jérôme
Abstract excerpt
BACKGROUND: Human Adenovirus (HAdV) are responsible for severe infections in hematopoietic stem cells transplant (HSCT) recipient, species C viruses being the most commonly observed in this population. There is no approved antiviral treatment yet. Cidofovir (CDV), a cytidine analog, is the most frequently used and its lipophilic conjugate, brincidofovir (BCV), is under clinical development. These drugs target the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
